title: Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients.
authors.forename: M
authors.initials: M
authors.lastname: Nevrly
authors.forename: P
authors.initials: P
authors.lastname: Kanovsky
authors.forename: H
authors.initials: H
authors.lastname: Vranova
authors.forename: K
authors.initials: K
authors.lastname: Langova
authors.forename: P
authors.initials: P
authors.lastname: Hlustik
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002396:Catechols / Q000627:therapeutic use*; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D002396:Catechols; D009570:Nitriles; D006710:Homocysteine; D007980:Levodopa; C071192:entacapone